{"id":"W4399302782","doi":"10.1097/hc9.0000000000000430","title":"Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future","year":2024,"lang":"en","type":"review","venue":"Hepatology Communications","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Genentech; Sirtex Medical; Ipsen; Eisai; Wellcome Trust; National Institute on Minority Health and Health Disparities; Stryker; Exelixis; Bayer HealthCare; Incyte; Boston Scientific Corporation; GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Contraindication; Oncology; Systemic therapy; Adjuvant; Adjuvant therapy; Clinical trial; Internal medicine; Intensive care medicine; Neoadjuvant therapy; Cancer; Breast cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006325831,0.0004375369,0.001521569,0.0008667236,0.000396023,0.002284749,0.0009688119,0.002458747,0.005078613],"category_scores_gemma":[0.004908354,0.0002996292,0.001022137,0.001167893,0.00188336,0.00417252,0.001067988,0.003522506,0.001266581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001122171,"about_ca_system_score_gemma":0.002918054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000815619,"about_ca_topic_score_gemma":0.00242666,"domain_scores_codex":[0.9990261,0.0003832233,0.0001551864,0.0001336468,0.0001954424,0.0001065222],"domain_scores_gemma":[0.9925947,0.004769823,0.0007536677,0.0001761006,0.001006107,0.0006997157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005914047,0.000214801,0.0008948154,0.004146719,0.00008115333,0.0000751965,0.00009354116,0.0005672723,0.0005530529,0.003997863,0.02091961,0.9678646],"study_design_scores_gemma":[0.0004097374,0.002245324,0.0076592,0.01504469,0.0006617046,0.001059471,0.0007491449,0.001804943,0.0007902212,0.02081813,0.948636,0.0001214063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001001959,0.982595,0.0003128307,0.01438002,0.0005456148,0.000006693902,0.00003882783,0.00002806678,0.001090976],"genre_scores_gemma":[0.01501021,0.9692262,0.001398958,0.008989069,0.004389015,0.00005553305,0.0001380662,0.0000207028,0.0007722367],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006325831,"threshold_uncertainty_score":0.03345454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1379420957450176,"score_gpt":0.3704256802017087,"score_spread":0.2324835844566912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}